Volvo Group - the third quarter 2020
GOTHENBURG, Sweden, Oct. 16, 2020 /PRNewswire/ -- "In Q3, utilization of trucks and machines gradually improved as COVID-19 restrictions were eased. Towards the end of the quarter transport activity was back on roughly the same level as a year ago in most markets. This led to an improved sentiment among our customers, which is reflected in increased order intake for trucks, engines and construction equipment as well as a gradually improving service business. In the last two quarters, our organization and business partners have shown great volume flexibility by first handling a dramatic volume decline and then a steep recovery with good productivity maintained. However, the weak order intake in the previous quarter impacted the Group's net sales in Q3, which amounted to SEK 76.9 billion - 16% lower than a year ago adjusted for currency. Our service business is more stable, with currency-adjusted revenues coming down by only 1% compared to Q3 last year and with a sequential improvement. Despite the sales decline we achieved an adjusted operating margin of 9.4% (11.0) thanks to significant cost reductions," says Martin Lundstedt, President and CEO.
- In Q3 2020, net sales amounted to SEK 76.9 billion (98.7). Adjusted for currency movements, net sales decreased by 16%.
- Adjusted operating income amounted to SEK 7,217 M (10,885), corresponding to an adjusted operating margin of 9.4% (11.0).
- Reported operating income amounted to SEK 7,508 M (10,885).
- Currency movements had a negative impact on operating income of SEK 1,499 M.
- Diluted earnings per share amounted to SEK 2.81 (3.67).
- Operating cash flow in the Industrial Operations was positive in an amount of SEK 11,712 M (1,831).
Press and Analyst Conference Call. An on-line presentation of the report, followed by a question-and-answer session will be webcast starting at 09.00 CEST. More information is available on the Volvo Group Investor page.
This information is information that AB Volvo (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07.20 CEST on October 16, 2020.
Aktiebolaget Volvo (publ) 556012-5790Investor Relations SE-405 08 Göteborg, SwedenTel +46 31 66 00 00 www.volvogroup.com
Contact Media Relations:Claes Eliasson +46 765 53 72 29
Contacts Investor Relations:Christer Johansson +46 739 02 25 22Johan Bartler +46 739 02 21 93Anders Christensson +46 765 53 59 66
October 16, 2020
For more information, please visit volvogroup.comThe Volvo Group drives prosperity through transport and infrastructure solutions, offering trucks, buses, construction equipment, power solutions for marine and industrial applications, financing and services that increase our customers' uptime and productivity. Founded in 1927, the Volvo Group is committed to shaping the future landscape of sustainable transport and infrastructure solutions. The Volvo Group is headquartered in Gothenburg, Sweden, employs almost 100.000 people and serves customers in more than 190 markets. In 2019, net sales amounted to about SEK 432 billion (EUR 40.5 billion). Volvo shares are listed on Nasdaq Stockholm.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/ab-volvo/r/volvo-group---the-third-quarter-2020,c3217160
The following files are available for download:
201016-volvo-group-report-q3-2020-eng.pdf | |
https://news.cision.com/ab-volvo/i/1860x1050-volvo-trucks-vnr-lights,c2839157 | 1860x1050-volvo-trucks-vnr-lights |
https://mb.cision.com/Public/39/3217160/b7a2624b523096ea.pdf | 201016-volvo-group-q3-press-release-eng |
View original content:http://www.prnewswire.com/news-releases/volvo-group--the-third-quarter-2020-301153856.html
SOURCE AB Volvo
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Are we witnessing a fundamental or speculative rally in the S&P 500?
- 2026 ASCO LBA | Juncell Therapeutics' GC101 TIL Therapy Achieves Primary Endpoint in the Pivotal Phase II Trial for PD-1 Antibody Failed Advanced Melanoma
- AI Poised to Transform Social Impact at Scale as BCG Commits $500 Million by End of 2030
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share